EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

Changyuan Yang iD, Petra Denig, Lynne Chepulis, Ryan G Paul, Jung-Im Shin iD, Ron T Gansevoort, Priya Vart iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70421 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Changyuan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Frailty, Healthcare Disparities. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.

Methods

This observational study analysed data from adults registered in primary care during 2023, using the Groningen Initiative to Analyse Type 2 Diabetes Treatment (GIANTT) database. Eligibility for SGLT2 inhibitor treatment was determined based on the Dutch College of General Practitioners (NHG) guideline for T2DM. Prescription rates were assessed across demographics, comorbidities, and preceding medication use. Multivariable logistic regression models were used to assess the association of age and identify factors associated with SGLT2 inhibitor prescriptions.

Results

Among 10 241 adults with T2DM, 41% ( n = 4223) were eligible for SGLT2 inhibitor prescription. The prescription rate in the overall population was 15.2% and among eligible people was 25.5%. In people eligible for SGLT2 inhibitors, prescription rates were markedly lower with increasing age, with 37.6% in those aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsFrailtyHealthcare DisparitiesPractice Patterns, Physicians'HumansMaleFemaleAgedMiddle AgedAged, 80 and overSex FactorsAge FactorsNetherlandsDrug PrescriptionsAdult

Stichwörter der Autor:innen

SGLT2ifrailtypharmacoepidemiologyprimary caretype 2 diabetes

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Division of Health, University of Waikato, Hamilton, New Zealand.
  • Waikato Regional Diabetes Service, Te Whatu Ora Health New Zealand Waikato, Hamilton, New Zealand.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Changyuan Yang, Jung-Im Shin, Priya Vart

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Yang, C., Denig, P., Chepulis, L., Paul, R. G., Shin, J. I., Gansevoort, R. T., & Vart, P. (2026). Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70421

Vancouver

Yang C, Denig P, Chepulis L, Paul RG, Shin JI, Gansevoort RT, et al. Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70421

BibTeX
@article{Yang2026,
  author = {Yang, Changyuan and Denig, Petra and Chepulis, Lynne and Paul, Ryan G and Shin, Jung-Im and Gansevoort, Ron T and Vart, Priya},
  title = {Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70421}
}
Kostenlos starten →